Published in TB and Outbreaks Week, September 23rd, 1996
The diagnosis of extrapulmonary M. tuberculosis has posed a difficult challenge. Commercial nucleic acid amplification kits are licensed for use with respiratory specimens only, and experience with specimens of nonrespiratory origin is still limited. Although some investigators have reported preliminary sensitivities and specificities similar to those obtained when respiratory samples are tested, it has been demonstrated that, at least with some specimens like...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.